↓ Skip to main content

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Overview of attention for article published in Psychopharmacology, September 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
10 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
463 Dimensions

Readers on

mendeley
296 Mendeley
citeulike
3 CiteULike
Title
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
Published in
Psychopharmacology, September 2003
DOI 10.1007/s00213-003-1582-z
Pubmed ID
Authors

John H. Krystal, D. Cyril D'Souza, Daniel Mathalon, Edward Perry, Aysenil Belger, Ralph Hoffman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 296 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 8 3%
Spain 2 <1%
Australia 2 <1%
United Kingdom 2 <1%
Canada 1 <1%
Portugal 1 <1%
Argentina 1 <1%
Germany 1 <1%
Japan 1 <1%
Other 1 <1%
Unknown 276 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 52 18%
Researcher 52 18%
Student > Master 42 14%
Student > Bachelor 35 12%
Professor > Associate Professor 15 5%
Other 49 17%
Unknown 51 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 57 19%
Neuroscience 51 17%
Medicine and Dentistry 50 17%
Psychology 37 13%
Biochemistry, Genetics and Molecular Biology 8 3%
Other 25 8%
Unknown 68 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2023.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Psychopharmacology
#1,323
of 5,320 outputs
Outputs of similar age
#9,631
of 54,002 outputs
Outputs of similar age from Psychopharmacology
#8
of 25 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,320 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 54,002 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.